Health Talks — COVID-19 and effective diagnostics: Key to recovery of health, society and economy

Health Talks — COVID-19 and effective diagnostics: Key to recovery of health, society and economy

Publication date: Sep 04, 2025

Uh we test for three genes and we also test we also include we add a virus to every sample and we test for that virus. Um and uh uh with the notion that probably the most important thing to get moving was testing. Do we know if co 19 is mutating to the point that the antibodies um may develop uh well one may develop won’t help if they get sick again. So, um this is some of the stuff that’s been going on in terms of logistical support to get samples uh and collection uh kits available. Um we, as I mentioned, we have a a participant portal where people can get online and actually register to get um tested. Um in terms of regulatory we have um obviously our safety approvals in place as well as um an IRB approval that was fasttracked for just collecting uh results. Um this is um the uh uh kind of outline of the equipment that we use to do the sampling.

Concepts Keywords
Arizona Corology
Dinner Corona
Fast Day
Physicians Important
Smartphone Josh
Positive
Question
Start
Talk
Test
Tested
Testing
Tests
Viral
Virus

Semantics

Type Source Name
disease MESH COVID-19
disease IDO role
disease IDO production
drug DRUGBANK Nonoxynol-9
disease MESH virus disease
disease IDO immune response
drug DRUGBANK Antithymocyte immunoglobulin (rabbit)
disease MESH Cancer
disease MESH death
disease MESH severe acute respiratory syndrome
disease MESH emergency
disease IDO blood
disease IDO protein
disease MESH viral load
disease MESH infection
disease IDO process
drug DRUGBANK Spinosad
drug DRUGBANK Tropicamide
disease IDO contact tracing
disease MESH privacy
disease MESH infectious disease
pathway REACTOME Infectious disease
drug DRUGBANK Troleandomycin
disease MESH influenza
disease IDO infectivity
disease IDO cell
disease IDO site
disease IDO assay
disease IDO entity
drug DRUGBANK Cysteamine
disease IDO quality
drug DRUGBANK Pirenzepine
disease MESH mutation rate
disease MESH AIDS
drug DRUGBANK Etoperidone
disease MESH back to work
disease IDO country

Original Article

(Visited 7 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *